<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04247334</url>
  </required_header>
  <id_info>
    <org_study_id>1352651-9</org_study_id>
    <nct_id>NCT04247334</nct_id>
  </id_info>
  <brief_title>Inhibitory Control: Effects of Modulation</brief_title>
  <official_title>Brain Circuitry of Inhibitory Control: Effects of Modulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inhibitory control is relevant to many clinical disorders, including substance
      abuse/dependence, obsessive-compulsive disorder, and attention-deficit hyperactivity
      disorder. This proposal is designed to assess brain networks related to response inhibition
      in healthy young adults, and use neuromodulation to change these networks and behavioral
      performance on a response inhibition task. Having an understanding of the brain mechanisms
      involved in response inhibition may enable us to improve pre-existing treatments for
      disorders with inhibitory control difficulties.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fMRI connectivity at rest</measure>
    <time_frame>2 weeks</time_frame>
    <description>Changes in resting state connectivity of the inhibitory control information</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fMRI connectivity during a stop signal task</measure>
    <time_frame>2 weeks</time_frame>
    <description>Changes in task-based connectivity on the stop signal task</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Young Adults</condition>
  <arm_group>
    <arm_group_label>Cautious Participants</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants who have low scores on a self-report of inhibitory control abilities (BRIEF-Inhibit).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Impulsive Participants- Active Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to active stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Impulsive Participants- Sham Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to sham stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>20 minutes of 2 milliamp transcranial direct current stimulation</description>
    <arm_group_label>Impulsive Participants- Active Stimulation</arm_group_label>
    <arm_group_label>Impulsive Participants- Sham Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Low (&lt;1sd below the mean on the BRIEF-Inhibit) or high (&gt;1sd above the mean on
             BRIEF-Inhibit scale)

          2. English fluency to ensure comprehension of study measures and instructions.

        Exclusion Criteria:

          1. Presence of medical conditions contraindicated for tDCS, including history of any
             known intracranial pathology, epilepsy or seizures, traumatic brain injury, brain
             tumor, stroke, implanted medical devices, current pregnancy or women of childbearing
             age not using effective contraception, or any other serious medical conditions or
             health problems that would interfere with participation (e.g., skin condition)

          2. Inability to undergo MRI

          3. Current substance abuse disorder

          4. Currently prescribed psychiatric medications.

          5. Active mania or psychosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole McLaughlin, PhD</last_name>
    <phone>4014556608</phone>
    <email>nmclaughlin@butler.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 24, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2020</study_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

